mapping the effectiveness and risks of glp-1 receptor agonists Researchers create an atlas health associations for GLP-1 Receptor Agonists and Research

In a recent UK Biobank cohort study of 25,596 participants, suPAR was a strong independent predictor of CKM outcomes [sub-hazard ratio (sHR)1.23], with a particularly high predictive value for CKD (sHR 1.41) (128)

Professor Goldsteins research contributions include: Co-discovery and isolation of the thymosin family of peptides in the 1960s First clinical trials of thymosin preparations in immunodeficient children (1974) Characterization of thymosin beta-4s actin-binding and wound healing properties Development of therapeutic applications for tissue repair and regeneration Over 450 published scientific articles and 25+ patents related to thymosins Leadership in translating thymosin research toward clinical development Disclaimer: This spotlight is provided for educational purposes to acknowledge scientific contributions to BPC-157 and TB-500/thymosin beta-4 research

Petropoulos S, Edsgrd D, Reinius B, et al

Stem Cells Int (2017) 2017:7428316